Dexiang Gao

6.6k total citations
147 papers, 4.1k citations indexed

About

Dexiang Gao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Dexiang Gao has authored 147 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 47 papers in Pulmonary and Respiratory Medicine and 27 papers in Molecular Biology. Recurrent topics in Dexiang Gao's work include Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Research Studies (12 papers). Dexiang Gao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Research Studies (12 papers). Dexiang Gao collaborates with scholars based in United States, China and Australia. Dexiang Gao's co-authors include Charles S. McHenry, Virginia F. Borges, Aik Choon Tan, Paul A. Bunn, Norman R. Friedman, Martin D. McCarter, Peter M. Mourani, Steven H. Abman, D. Dunbar Ivy and Pepper Schedin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dexiang Gao

142 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dexiang Gao United States 39 1.3k 1.1k 1.1k 646 609 147 4.1k
Jianguang Ji Sweden 40 1.1k 0.9× 889 0.8× 836 0.8× 921 1.4× 708 1.2× 197 4.9k
Irene Helenowski United States 39 1.7k 1.4× 898 0.8× 967 0.9× 683 1.1× 877 1.4× 232 5.7k
Franz Quehenberger Austria 34 866 0.7× 886 0.8× 1.2k 1.1× 612 0.9× 809 1.3× 193 4.6k
Yoshinori Okada Japan 33 759 0.6× 889 0.8× 1.4k 1.4× 509 0.8× 1.1k 1.8× 315 4.0k
Jennifer Turner Australia 38 1.2k 0.9× 960 0.9× 822 0.8× 416 0.6× 474 0.8× 144 4.8k
Naoko Kinukawa Japan 47 1.1k 0.9× 1.1k 1.0× 1.4k 1.3× 901 1.4× 1.1k 1.8× 191 6.5k
Felix Niggli Switzerland 44 1.7k 1.3× 2.2k 1.9× 1.8k 1.7× 531 0.8× 425 0.7× 206 6.8k
John T. Sandlund United States 60 2.3k 1.8× 1.7k 1.6× 1.1k 1.0× 404 0.6× 519 0.9× 169 10.5k
Klaus Müller Denmark 38 637 0.5× 1.5k 1.4× 781 0.7× 683 1.1× 498 0.8× 217 5.5k
Koji Matsuo United States 42 1.5k 1.2× 895 0.8× 706 0.7× 1.4k 2.2× 1.2k 2.0× 517 7.8k

Countries citing papers authored by Dexiang Gao

Since Specialization
Citations

This map shows the geographic impact of Dexiang Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dexiang Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dexiang Gao more than expected).

Fields of papers citing papers by Dexiang Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dexiang Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dexiang Gao. The network helps show where Dexiang Gao may publish in the future.

Co-authorship network of co-authors of Dexiang Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Dexiang Gao. A scholar is included among the top collaborators of Dexiang Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dexiang Gao. Dexiang Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilky, Breelyn A., Alessandra Maleddu, Dexiang Gao, et al.. (2025). A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti–CTLA-4 Antibody) and Balstilimab (Anti–PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas. Clinical Cancer Research. 31(14). 2945–2956. 1 indexed citations
2.
Shagisultanova, Elena, et al.. (2025). Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer. Clinical Breast Cancer. 25(7). 643–649.e1.
3.
Tsui, David Chun Cheong, Douglas E. Holt, Tejas Patil, et al.. (2024). The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer. Advances in Radiation Oncology. 9(7). 101516–101516. 2 indexed citations
4.
Shagisultanova, Elena, William J. Gradishar, Pavani Chalasani, et al.. (2023). Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer. Clinical Cancer Research. 29(24). 5021–5030. 8 indexed citations
5.
Wang, Zhaohui, Huiping Zhang, David W. Mathes, et al.. (2023). CCR4‐IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T‐cell lymphoma in a mouse CTCL model. FEBS Open Bio. 13(7). 1309–1319. 9 indexed citations
6.
Nieto, Cera, Bettina Miller, Molishree Joshi, et al.. (2023). The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma. JNCI Journal of the National Cancer Institute. 115(11). 1392–1403. 9 indexed citations
7.
Shagisultanova, Elena, Dexiang Gao, Eryn Callihan, et al.. (2022). Overall survival is the lowest among young women with postpartum breast cancer. European Journal of Cancer. 168. 119–127. 13 indexed citations
8.
Holt, Douglas E., Colton Ladbury, Dexiang Gao, et al.. (2022). The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Oral Oncology. 130. 105907–105907. 2 indexed citations
9.
Yamauchi, Takeshi, Zili Zhai, Dinoop Ravindran Menon, et al.. (2021). Global Melanoma Correlations With Obesity, Smoking, and Alcohol Consumption. JMIR Dermatology. 4(2). e31275–e31275. 4 indexed citations
10.
Weiss, Jennifer, Dexiang Gao, Christine M. Fisher, et al.. (2020). Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center. Cancer Medicine. 9(23). 8801–8808. 1 indexed citations
11.
Simons, Emily, Derek Smith, Dexiang Gao, & D. Ross Camidge. (2020). Variation in Toxicity Reporting Methods for Early Phase Lung Cancer Treatment Trials at Oncology Conferences. Journal of Thoracic Oncology. 15(9). 1425–1433. 7 indexed citations
12.
Helfrich, Barbara A., Jihye Kim, Dexiang Gao, et al.. (2016). Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. Molecular Cancer Therapeutics. 15(10). 2314–2322. 83 indexed citations
13.
Yu, Hui, Yayi He, Christopher J. Rivard, et al.. (2016). PS01.20: Immune Checkpoints Expression in Small Cell Lung Cancer Lines. Journal of Thoracic Oncology. 11(11). S281–S281. 1 indexed citations
14.
Merrick, Daniel T., Dexiang Gao, York E. Miller, et al.. (2015). Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma. Cancer Prevention Research. 9(1). 96–104. 24 indexed citations
15.
Wynes, Murry W., Trista K. Hinz, Dexiang Gao, et al.. (2014). FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies. Clinical Cancer Research. 20(12). 3299–3309. 125 indexed citations
16.
Casás‐Selves, Matias, Jihye Kim, Zhiyong Zhang, et al.. (2012). Tankyrase and the Canonical Wnt Pathway Protect Lung Cancer Cells from EGFR Inhibition. Cancer Research. 72(16). 4154–4164. 109 indexed citations
17.
Gao, Dexiang, et al.. (2006). Time-Varying Risk Factors for Long-Term Mortality After Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery. 81(3). 793–799. 32 indexed citations
18.
Kappy, Michael S., et al.. (2006). Assessing adrenal function in primary care settings with a single sample subcutaneous glucagon test. The Journal of Pediatrics. 149(5). 682–686. 15 indexed citations
19.
O’Connor, Mary E., et al.. (2006). Effect of Open Access Scheduling on Missed Appointments, Immunizations, and Continuity of Care for Infant Well-Child Care Visits. Archives of Pediatrics and Adolescent Medicine. 160(9). 889–93. 45 indexed citations
20.
Mourani, Peter M., D. Dunbar Ivy, Dexiang Gao, & Steven H. Abman. (2004). Pulmonary Vascular Effects of Inhaled Nitric Oxide and Oxygen Tension in Bronchopulmonary Dysplasia. American Journal of Respiratory and Critical Care Medicine. 170(9). 1006–1013. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026